BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 23711220)

  • 21. Contribution of Peptide Backbone to Anti-Citrullinated Peptide Antibody Reactivity.
    Trier NH; Dam CE; Olsen DT; Hansen PR; Houen G
    PLoS One; 2015; 10(12):e0144707. PubMed ID: 26657009
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An investigation of the added value of an ACPA multiplex assay in an early rheumatoid arthritis setting.
    van Heemst J; Trouw LA; Nogueira L; van Steenbergen HW; van der Helm-van Mil AH; Allaart CF; Serre G; Holmdahl R; Huizinga TW; Toes RE; van der Woude D
    Arthritis Res Ther; 2015 Oct; 17():276. PubMed ID: 26437716
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multiple antibody reactivities to citrullinated antigens in sera from patients with rheumatoid arthritis: association with HLA-DRB1 alleles.
    Snir O; Widhe M; von Spee C; Lindberg J; Padyukov L; Lundberg K; Engström A; Venables PJ; Lundeberg J; Holmdahl R; Klareskog L; Malmström V
    Ann Rheum Dis; 2009 May; 68(5):736-43. PubMed ID: 18635594
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Affinity Maturation of the Anti-Citrullinated Protein Antibody Paratope Drives Epitope Spreading and Polyreactivity in Rheumatoid Arthritis.
    Kongpachith S; Lingampalli N; Ju CH; Blum LK; Lu DR; Elliott SE; Mao R; Robinson WH
    Arthritis Rheumatol; 2019 Apr; 71(4):507-517. PubMed ID: 30811898
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Are there autoantibodies reacting against citrullinated peptides derived from type I and type II collagens in patients with rheumatoid arthritis?
    Koivula MK; Aman S; Karjalainen A; Hakala M; Risteli J
    Ann Rheum Dis; 2005 Oct; 64(10):1443-50. PubMed ID: 16162901
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of the anti-citrullinated protein antibody repertoire prior to the onset of rheumatoid arthritis.
    van de Stadt LA; de Koning MH; van de Stadt RJ; Wolbink G; Dijkmans BA; Hamann D; van Schaardenburg D
    Arthritis Rheum; 2011 Nov; 63(11):3226-33. PubMed ID: 21792832
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epitope mapping with synthetic peptides of 52-kD SSA/Ro protein reveals heterogeneous antibody profiles in human autoimmune sera.
    Ricchiuti V; Briand JP; Meyer O; Isenberg DA; Pruijn G; Muller S
    Clin Exp Immunol; 1994 Mar; 95(3):397-407. PubMed ID: 7511075
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibodies to citrullinated alpha-enolase peptide 1 are specific for rheumatoid arthritis and cross-react with bacterial enolase.
    Lundberg K; Kinloch A; Fisher BA; Wegner N; Wait R; Charles P; Mikuls TR; Venables PJ
    Arthritis Rheum; 2008 Oct; 58(10):3009-19. PubMed ID: 18821669
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bacterial citrullinated epitopes generated by
    Jenning M; Marklein B; Ytterberg J; Zubarev RA; Joshua V; van Schaardenburg D; van de Stadt L; Catrina AI; Nonhoff U; Häupl T; Konthur Z; Burmester GR; Skriner K
    Ann Rheum Dis; 2020 Sep; 79(9):1194-1202. PubMed ID: 32532752
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epitope spreading of the anti-citrullinated protein antibody response occurs before disease onset and is associated with the disease course of early arthritis.
    van der Woude D; Rantapää-Dahlqvist S; Ioan-Facsinay A; Onnekink C; Schwarte CM; Verpoort KN; Drijfhout JW; Huizinga TW; Toes RE; Pruijn GJ
    Ann Rheum Dis; 2010 Aug; 69(8):1554-61. PubMed ID: 20448290
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic value of anti-mutated citrullinated vimentin in comparison to anti-cyclic citrullinated peptide and anti-viral citrullinated peptide 2 antibodies in rheumatoid arthritis: an Italian multicentric study and review of the literature.
    Bartoloni E; Alunno A; Bistoni O; Bizzaro N; Migliorini P; Morozzi G; Doria A; Mathieu A; Lotzniker M; Allegri F; Riccieri V; Alpini C; Gabrielli A; Tampoia M; Gerli R;
    Autoimmun Rev; 2012 Sep; 11(11):815-20. PubMed ID: 22394488
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The antigen specificity of the rheumatoid arthritis-associated ACPA directed to citrullinated fibrin is very closely restricted.
    Iobagiu C; Magyar A; Nogueira L; Cornillet M; Sebbag M; Arnaud J; Hudecz F; Serre G
    J Autoimmun; 2011 Dec; 37(4):263-72. PubMed ID: 21872430
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Autoantibodies From Single Circulating Plasmablasts React With Citrullinated Antigens and Porphyromonas gingivalis in Rheumatoid Arthritis.
    Li S; Yu Y; Yue Y; Liao H; Xie W; Thai J; Mikuls TR; Thiele GM; Duryee MJ; Sayles H; Payne JB; Klassen LW; O'Dell JR; Zhang Z; Su K
    Arthritis Rheumatol; 2016 Mar; 68(3):614-26. PubMed ID: 26474325
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The ACPA recognition profile and subgrouping of ACPA-positive RA patients.
    Willemze A; Böhringer S; Knevel R; Levarht EW; Stoeken-Rijsbergen G; Houwing-Duistermaat JJ; van der Helm-van Mil AH; Huizinga TW; Toes RE; Trouw LA
    Ann Rheum Dis; 2012 Feb; 71(2):268-74. PubMed ID: 21998120
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-citrullinated protein/peptide antibodies (ACPA) in rheumatoid arthritis: specificity and relation with rheumatoid factor.
    Vander Cruyssen B; Peene I; Cantaert T; Hoffman IE; De Rycke L; Veys EM; De Keyser F
    Autoimmun Rev; 2005 Sep; 4(7):468-74. PubMed ID: 16137613
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative analysis of autoantibodies targeting peptidylarginine deiminase type 4, mutated citrullinated vimentin and cyclic citrullinated peptides in rheumatoid arthritis: associations with cytokine profiles, clinical and genetic features.
    Reyes-Castillo Z; Palafox-Sánchez CA; Parra-Rojas I; Martínez-Bonilla GE; del Toro-Arreola S; Ramírez-Dueñas MG; Ocampo-Bermudes G; Muñoz-Valle JF
    Clin Exp Immunol; 2015 Nov; 182(2):119-31. PubMed ID: 26149185
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relatedness of Antibodies to Peptides Containing Homocitrulline or Citrulline in Patients with Rheumatoid Arthritis.
    Lac P; Racapé M; Barra L; Bell DA; Cairns E
    J Rheumatol; 2018 Mar; 45(3):302-309. PubMed ID: 29196382
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The fine specificity of IgM anti-citrullinated protein antibodies (ACPA) is different from that of IgG ACPA.
    Suwannalai P; Willemze A; van Toorn L; Stoeken-Rijsbergen G; Levarht N; Drijfhout JW; Huizinga TW; Toes RE; Trouw LA
    Arthritis Res Ther; 2011; 13(6):R195. PubMed ID: 22129077
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differences in the Spectrum of Anti-Citrullinated Protein Antibody Fine Specificities Between Malaysian and Swedish Patients With Rheumatoid Arthritis: Implications for Disease Pathogenesis.
    Too CL; Murad S; Hansson M; Alm LM; Dhaliwal JS; Holmdahl R; Jakobsson PJ; Alfredsson L; Klareskog L; Rönnelid J; Padyukov L
    Arthritis Rheumatol; 2017 Jan; 69(1):58-69. PubMed ID: 27483449
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fine specificity of autoantibodies to calreticulin: epitope mapping and characterization.
    Eggleton P; Ward FJ; Johnson S; Khamashta MA; Hughes GR; Hajela VA; Michalak M; Corbett EF; Staines NA; Reid KB
    Clin Exp Immunol; 2000 May; 120(2):384-91. PubMed ID: 10792392
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.